PT2.12.03 Zongertinib in Patients With Previously Treated HER2-Mutant NSCLC and Brain Metastases at Baseline: Beamion LUNG-1

作者：G. Ruiter, E.F. Smit, Ross A. Soo, N. Girard, D. Planchard, M-J. Ahn, E. Nadal, Yi‐Long Wu, J. Zugazagoitia, N. Yamamoto, B.C. Cho, C Kim, Jae Hyoung Park, Kiyotaka Yoh, B. Sadrolhefazi, K. Fernamberg, L. Schroeter, John V. Heymach · 发表于：Journal of Thoracic Oncology · 年份：2025 · DOI：10.1016/j.jtho.2025.09.1159 · 被引用次数：5 · 研究领域：Lung Cancer Treatments and Mutations、Chronic Myeloid Leukemia Treatments、PI3K/AKT/mTOR signaling in cancer